HOME >> MEDICINE >> NEWS
USC/Norris Study Finds No Benefit Of Finasteride In Preventing Prostate Cancer In Men At Elevated Risk


Study Suggests That Drug Could Leave Certain Men At Higher Risk

LOS ANGELES, Calif., Aug. 1, 1998 -- A new study by USC/Norris Cancer Center scientists raises serious questions about the potential use of the drug finasteride to prevent prostate cancer.

Scientists have theorized that finasteride, sold under the brand name Proscar and commonly used to treat benign prostate disease, might offer men a way to cut their risk of developing prostate cancer.

Yet, "it appears that finasteride may not be effective as a chemopreventive agent against prostate cancer, at least in men with high PSA levels," says Ronald K. Ross, M.D., USC professor of preventive medicine and deputy director of the USC/Norris Cancer Center.

"There may even be a subgroup of patients in whom the drug actually could be harmful," says co-author Richard J. Cote, M.D., USC associate professor of pathology and urology. Ross and Cote, along with Eila C. Skinner, M.D., USC associate professor of urology, led the study, which appears in the first August issue of the British Journal of Cancer.

Prostate cancer is the most frequently diagnosed cancer in the United States, and proves fatal for some 40,000 men each year. At present, there's no proven way to prevent the disease.

USC/Norris researchers have long led research on the role of the male hormones androgens in spurring prostate cancer growth. Ross and his colleagues first proposed that lowering levels of the androgen most active in the prostate, called dihydrotestosterone (DHT), could possibly prevent prostate cancer. Ross' team was also the first to suggest that finasteride, which lowers the levels of DHT by blocking the enzyme that converts testosterone into DHT, might prevent the formation of prostate cancer.

The National Cancer Institute (NCI) is in the midst of a large national clinical trial to determine if finasteride can reduce the incidence of prostate cancer. The seven-year NCI study has
'"/>

Contact: Eva Emerson or Brenda Maceo
eemerson@hsc.usc.edu
323-442-2830
University of Southern California
1-Aug-1998


Page: 1 2 3 4

Related medicine news :

1. USC/Norris oncologists test new front-line therapy for pancreatic cancer
2. Study of energy and health in Africa focuses spotlight on charcoal and forest management
3. Study shows promise in identifying kidney failure
4. Study shows patch therapy may be as effective as oral medications
5. Study shows soy is well accepted in school lunches
6. Study finds that coordinating care of chronically ill patients does not increase liability
7. Study provides new estimates of the causes of child mortality worldwide
8. Study finds factors linked to substance use disorder relapse among health care professionals
9. Study finds majority of women willing to accept cervical cancer vaccine for self and children
10. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
11. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2020)... ... June 26, 2020 , ... The Pool & ... and redesignation of the ANSI/APSP/ICC-7 2013 American National Standard for Suction Entrapment Avoidance ... seeking member participation on the PHTA-7 Standard Writing Committee (SWC) for Suction Entrapment ...
(Date:6/28/2020)... ... ... The secret of surviving a pandemic with one’s sanity intact does not ... was the first product to disappear off the shelves when the COVID-19 crisis began. ... less need to venture out, the longer you can “survive”. However, does all this ...
(Date:6/24/2020)... ... , ... Evolved Naturals, a new brand of CBD health and beauty products, ... newly launched website showcases a variety of health and beauty CBD products ... skincare & topical products . , Doug Gee, the CEO of Evolved ...
(Date:6/24/2020)... ... June 24, 2020 , ... Skyroam , the developer of ... LabWare , the leading provider of enterprise software for testing laboratories, in which ... of LabWare’s new Portable Disease Surveillance Lab (PDSL) kit. , “Stopping the spread of ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... and specialty physician practices from international healthcare accounts receivables, announced today its ... partnership will enable Sunbelt Health Partners to seamlessly deliver an end-to-end patient ...
Breaking Medicine News(10 mins):
(Date:6/23/2020)... ... June 23, 2020 , ... Today Project ... of the first online COVID-19 trainings for health workers and others on the ... training entitled COVID-19 Training for Health Workers: Preparedness and Response are ...
(Date:6/23/2020)... (PRWEB) , ... June 23, 2020 , ... ... that describes how the company’s technology can be used to test an in ... The study was part of a collaboration between Draper and the ...
(Date:6/23/2020)... ... June 23, 2020 , ... One size fits all may work ... prove a similar, universal program does not work as an overall response to the ... everyone’s daily life in one way or another, from plummeting stock markets and rising ...
Breaking Medicine Technology:
Cached News: